US FDA Kills Voluntary ISO Audit Program For Medtech As MDSAP Efforts Accelerate
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has terminated its three-year-old ISO 13485 voluntary audit program, which gave medtech companies the chance for a one-year reprieve from an FDA inspection, to put all attention on the global Medical Device Single Audit Program.